Cited by 2Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and ApplicationsAlzheimer's disease research and treatments

The DOI matches its Crossref record.

Sex and APOE genotype‐specific white matter changes in Alzheimer’s disease

Horgusluoglu‐Moloch, Emrin, Wang, Minghui, Zhou, Xianxiao, Zeng, Qi, Zhang, Bin·2021·Alzheimer's & Dementia

Abstract

Background: APOE ε4 genotype and sex difference represent strong risk factors for Alzheimer’s Disease (AD) that also lead to white matter (WM) microstructural changes. However, it is still not clear which brain regions have the strongest changes with APOE ε3 and ε4 allele carrier status and sex difference, and what are the key drivers and biological pathways underlying WM abnormality during disease progression. In this study, we present a new comprehensive framework to identify sex‐ and APOE genotype‐specific WM changes in specific brain regions with AD severity using the data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI‐GO/2). Method: DTI‐derived features including fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (L1), radial diffusivity (RD) were calculated from ADNIGO/2 (N = 232). ADNI participants were classified depending on their sex and APOE genotype status as female APOE ε3/3, male APOE ε3/3, female APOE ε4 positive, and male APOE ε4 positive. Through correlating DTI features with the clinical/cognitive traits, we systematically rank‐ordered 176 brain regions in relation to disease severity for each group. Multiscale Embedded Gene co‐Expression Network Analysis (MEGENA) was performed using processed expression data to identify clusters of highly correlated genes and DTI‐features as modules. Gene Set Enrichment Analysis (GSEA) was carried out to annotate each module with enriched pathways for each group. Result: The parahippocampal gyrus (PHG)‐right, posterior thalamic radiation (PTR)‐left, hippocampus (HIPPO)‐left, and the superior temporal gyrus (STG)‐right were top‐ranked regions with sex and APOE ε3 and ε4 alleles carrier status (Figure 1A‐D). WM changes in PTR‐right are the only specific for the male APOE ε4+ group compared to the other groups. PHG‐right is highly associated with worse AD clinical outcomes in APOE ε4 allele carriers regardless of sex difference. DTI features in MTWM‐left is significantly correlated with only female APOE ε3 group. Besides, the immune system, mitochondrial regulation, and myeloid cell differentiation are among the pathways enriched with modules in different sex and APOE genotype groups in top brain regions (Table 1). Conclusion: Enhanced understanding of the biological processes and key drivers related to sex‐ and APOE genotype‐specific WM microstructural changes could lead to novel therapeutic strategies for AD.

Overview

Integrity signals

Registry

Crossref · 10.1002/alz.055755

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies reporting sex-specific associations of APOE4 with WM integrity and stronger APOE-related differences in brain metabolism and cortical atrophy for women than men provide grounds for deeper exploration of sex differences.

    “studies reporting sex-specific associations of APOE4 with WM integrity [19] and stronger APOE-related differences in brain metabolism and cortical atrophy for women than men [20, 21] provide grounds for deeper exploration of sex differences in underlying cytoarchitecture.”

Citations

Cited by

Sorted by citations

Metadata

Authors
Horgusluoglu‐Moloch, E., Wang, M., Zhou, X., Zeng, Q., & Zhang, B.
Affiliations
  • Icahn Institute of Genomics and Multiscale Biology New York NY USA
  • Icahn School of Medicine at Mount Sinai (US)
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2021-12
Volume
17
Issue
S1
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W4205711030
Cited by
2
References
0
Citations by year
2024: 2
FWCI
0.36
Type
journal article
Language
en
Open access
closed
Locations
Alzheimer s & Dementia (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, APOE ε4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review